The global 3D Cell Culture Market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.
As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.
Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.
The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration
Like it? Share it!
About the Author
Ryan Shaw Joined: August 11th, 2017 Articles Posted: 601
